TSHR and Graves disease: The fact that a human monoclonal blocking antibody was developed from a patient with Graves’ disease (14) was also proof that such antibodies can be found in patients with Graves’ disease just as stimulating TSHR antibodies may occur in Hashimoto’s thyroiditis (17) where the gland is unable to respond to the stimulation.